Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
240.00
Ask:
250.00
Spread: 10.00 (4.167%)
Market Cap: £118.72m
QTX Live PriceLast checked at - London Stock Exchange

Intraday Quartix Tech Share Chart

Trading Update

10 Oct 2022 07:00

RNS Number : 2327C
Quartix Technologies PLC
10 October 2022
 

Quartix Technologies plc

("Quartix", "the Group" or "the Company")

Trading Update

 

 

Q3 Trading update

 

The Board is pleased to report that the rate of year-on-year growth in both annualised recurring revenue and unit installs continued to be strong in the third quarter.  These growth rates are expected to continue in the last quarter of the year.

The annualised recurring revenue of the fleet subscription base was £26.9m on 1 October, representing a gain, in constant currency terms, of £2.6m year on year, based on exchange rates as at 1 October 2022.

The Company's subscription base has grown by 17% year on year, to just over 229,000 vehicles. New units installed in the first 9 months of the year have increased by 24% compared with the same period in 2021. Growth in new subscriptions for the first 9 months of 2022 are shown in the table below.

 

Region

New subscriptions

(units)

first 9 months 2022

New subscriptions

(units)

first 9 months 2021

Growth

UK

20,714

17,703

17%

France

12,523

8,502

47%

USA

7,269

6,881

6%

Spain, Italy, Germany

6,060

4,586

32%

Total

46,566

37,672

24%

 

The Board is pleased to confirm that it expects revenue, profit and free cash flow for the year to 31 December 2022 to be in line with current consensus market forecasts, which are shown at the foot of this announcement1.

 

Richard Lilwall, CEO of Quartix, commented:

 

"We are delighted with the continuing growth in ARR to £26.9m at the end of the third quarter, in line with our expectations. We are also very pleased with growth in new subscriptions being particularly led by France followed by further progress in other European countries. The UK continues to deliver double digit growth in a more mature market. Our strategy for increasing the subscription base in the US continues to be refined."

 

The Board believes that consensus market expectations for 2022 prior to this announcement, were as follows: Revenue: £27.4m; Adjusted EBITDA £5.7m; Free Cash Flow: £4.1m.

 

 

For further information, please contact:

Quartix (www.quartix.com)

Richard Lilwall, Chief Executive Officer

Emily Rees, Chief Financial Officer

 

01686 806 663

finnCap (Nominated Adviser and Broker)

Matt Goode / Seamus Fricker / Milesh Hindocha (Corporate Finance)

Alice Lane (Corporate Broking)

020 7220 0500

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVEIVLDIIF
Date   Source Headline
31st Jul 20237:00 amRNSInterim Results
10th Jul 20237:00 amRNSInterim Results Timetable and Trading Update
7th Jul 20237:00 amRNSDirectorate Change
12th Jun 20231:45 pmRNSPDMR Shareholding
28th Mar 20235:40 pmRNSPDMR Shareholding
24th Mar 20236:05 pmRNSResult of AGM
24th Mar 20237:00 amRNSAGM Trading Statement
22nd Mar 20234:40 pmRNSPDMR Shareholding
27th Feb 20237:00 amRNSFinal Results
11th Jan 20237:00 amRNSTrading Statement
22nd Dec 20223:00 pmRNSSurrender and Granting of Options
20th Dec 20222:30 pmRNSDirectorate Succession
6th Dec 202211:40 amRNSHolding(s) in Company
10th Oct 20227:00 amRNSTrading Update
9th Sep 20225:20 pmRNSHolding(s) in Company
1st Aug 20222:11 pmRNSHolding(s) in Company
27th Jul 20227:00 amRNSInterim Results
11th Jul 20227:00 amRNSInterim Results Timetable and Trading Update
8th Jun 20223:45 pmRNSPDMR Shareholding
7th Jun 20225:10 pmRNSPDMR Shareholding
25th May 20221:10 pmRNSExercise of Share Options
26th Apr 20223:25 pmRNSPDMR Shareholding
25th Apr 20221:10 pmRNSPDMR Shareholding
20th Apr 202210:35 amRNSHolding(s) in Company
14th Apr 202210:40 amRNSPDMR Shareholding
7th Apr 20225:15 pmRNSPDMR Shareholding
4th Apr 20223:55 pmRNSPDMR Shareholding
23rd Mar 20224:45 pmRNSResult of AGM
23rd Mar 20227:00 amRNSAGM Trading Statement
11th Mar 20225:07 pmRNSHolding(s) in Company
28th Feb 20227:00 amRNSFinal Results
2nd Feb 20227:00 amRNSAward of London Stock Exchange Green Economy Mark
10th Jan 20227:00 amRNSTrading Statement
22nd Oct 20215:45 pmRNSCEO Succession Update and Trading Update
21st Oct 20218:15 amRNSHolding(s) in Company
13th Oct 20217:00 amRNSCEO Succession Update and Trading Update
6th Oct 20215:30 pmRNSDirector/PDMR Shareholding
1st Oct 20215:15 pmRNSTotal Voting Rights
28th Sep 20212:15 pmRNSExercise of Options, Director Shareholding and TVR
20th Sep 20211:42 pmRNSHolding(s) in Company
23rd Aug 20212:15 pmRNSDirector/PDMR Shareholding
17th Aug 20215:35 pmRNSPDMR Shareholding
12th Aug 20218:15 amRNSExercise of Options, Director Shareholding and TVR
2nd Aug 20217:00 amRNSDirector/PDMR Shareholding
28th Jul 20217:00 amRNSInterim Results
21st Jul 20217:00 amRNSDirectorate Change
7th Jul 20217:00 amRNSInterim Results Timetable and Trading Update
1st Jul 20215:00 pmRNSTotal Voting Rights
23rd Jun 20211:45 pmRNSExercise of Options, Director Shareholding & TVR
9th Jun 20219:01 amRNSChange of Name and Registered Address

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.